Search

Search Constraints

You searched for: Author/Creator Raptis, Anastasios

Search Results

12. Inferior outcome after allogeneic transplant in first remission in high‐risk AML patients who required more than two cycles of induction therapy. Issue 8 (August 2015)

13. Intensive induction chemotherapy vs hypomethylating agent–based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia. Issue 2 (30th June 2017)

14. Leukapheresis in patients newly diagnosed with acute myeloid leukemia. Issue 2 (October 2016)

15. Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma. Issue 7 (1st March 2021)

16. Outcome of acute myeloid leukemia patients with pulmonary nodules of uncertain etiology receiving allogeneic hematopoietic progenitor cell transplant. (17th April 2015)

17. Outcomes of patients diagnosed with acute myeloid leukemia after solid organ transplantation. Issue 9 (9th August 2017)

18. Patient and family caregiver dyadic adherence to the allogeneic hematopoietic cell transplantation medical regimen. Issue 1 (8th March 2017)

19. Patient‐reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study. (21st October 2021)

20. Peri‐transplant clostridium difficile infections in patients undergoing allogeneic hematopoietic progenitor cell transplant. Issue 3 (22nd February 2016)